Neurocrine Biosciences Inc (NASDAQ:NBIX)

98.23
Delayed Data
As of Jun 24
 +0.84 / +0.86%
Today’s Change
71.88
Today|||52-Week Range
108.02
+15.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$9.4B

Company Description

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The firm's product includes INGREZZA. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Contact Information

Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego California 92130
P:(858) 617-7600
Investor Relations:
(858) 617-7143

Employees

Shareholders

Individual stakeholders8.53%
Mutual fund holders58.96%
Other institutional37.16%

Top Executives

Kevin Charles GormanChief Executive Officer & Director
Bill WilsonVice President-Information Technology & Operations
Matthew C. AbernethyChief Financial Officer
Dimitri E. GrigoriadisChief Research Officer
Eiry W. RobertsChief Medical Officer